Predict your next investment

HEALTHCARE | Drug Development

See what CB Insights has to offer

Stage

Series A | Alive

Total Raised

$5M

Last Raised

$5M | 8 yrs ago

About Kurobe Pharmaceuticals

Kurobe Pharmaceuticals is developing a vancomycin formulation for anitbiotic-resistant eye infections.

Kurobe Pharmaceuticals Headquarter Location

400 N Ashley Drive Suite 2150

Tampa, Florida, 33602,

United States

813-579-2550

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Kurobe Pharmaceuticals Patents

Kurobe Pharmaceuticals has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/24/2014

1/26/2016

Ointments, Dosage forms, Bacterial diseases, Inflammations, Drug delivery devices

Grant

Application Date

9/24/2014

Grant Date

1/26/2016

Title

Related Topics

Ointments, Dosage forms, Bacterial diseases, Inflammations, Drug delivery devices

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.